• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of gutGutCurrent TOCInstructions to authors
Gut. Feb 1999; 44(2): 283–289.
PMCID: PMC1727393

Cytokine regulation of epithelial permeability and ion transport

Full Text

The Full Text of this article is available as a PDF (142K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Braegger CP, MacDonald TT. Immune mechanisms in chronic inflammatory bowel disease. Ann Allergy. 1994 Feb;72(2):135–141. [PubMed]
  • Radford-Smith G, Jewell DP. Cytokines and inflammatory bowel disease. Baillieres Clin Gastroenterol. 1996 Mar;10(1):151–164. [PubMed]
  • Brynskov J, Nielsen OH, Ahnfelt-Rønne I, Bendtzen K. Cytokines in inflammatory bowel disease. Scand J Gastroenterol. 1992 Nov;27(11):897–906. [PubMed]
  • Remick DG, Kunkel SL. Pathophysiologic alterations induced by tumor necrosis factor. Int Rev Exp Pathol. 1993;34(Pt B):7–25. [PubMed]
  • Garside P, Bunce C, Tomlinson RC, Nichols BL, Mowat AM. Analysis of enteropathy induced by tumour necrosis factor alpha. Cytokine. 1993 Jan;5(1):24–30. [PubMed]
  • Arend WP. Inhibiting the effects of cytokines in human diseases. Adv Intern Med. 1995;40:365–394. [PubMed]
  • Perdue MH, McKay DM. Integrative immunophysiology in the intestinal mucosa. Am J Physiol. 1994 Aug;267(2 Pt 1):G151–G165. [PubMed]
  • Unno N, Menconi MJ, Smith M, Fink MP. Nitric oxide mediates interferon-gamma-induced hyperpermeability in cultured human intestinal epithelial monolayers. Crit Care Med. 1995 Jul;23(7):1170–1176. [PubMed]
  • Di Paolo MC, Merrett MN, Crotty B, Jewell DP. 5-Aminosalicylic acid inhibits the impaired epithelial barrier function induced by gamma interferon. Gut. 1996 Jan;38(1):115–119. [PMC free article] [PubMed]
  • Gustafson-Svärd C, Tagesson C, Boll RM, Kald B. Tumor necrosis factor-alpha potentiates phospholipase A2-stimulated release and metabolism of arachidonic acid in cultured intestinal epithelial cells (INT 407). Scand J Gastroenterol. 1993 Apr;28(4):323–330. [PubMed]
  • McKay DM, Philpott DJ, Perdue MH. Review article: In vitro models in inflammatory bowel disease research--a critical review. Aliment Pharmacol Ther. 1997 Dec;11 (Suppl 3):70–80. [PubMed]
  • Castro GA, Arntzen CJ. Immunophysiology of the gut: a research frontier for integrative studies of the common mucosal immune system. Am J Physiol. 1993 Oct;265(4 Pt 1):G599–G610. [PubMed]
  • Brandtzaeg P, Halstensen TS, Kett K, Krajci P, Kvale D, Rognum TO, Scott H, Sollid LM. Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenterology. 1989 Dec;97(6):1562–1584. [PubMed]
  • Kagnoff MF, Eckmann L. Epithelial cells as sensors for microbial infection. J Clin Invest. 1997 Jul 1;100(1):6–10. [PMC free article] [PubMed]
  • Tilg H, Dinarello CA, Mier JW. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today. 1997 Sep;18(9):428–432. [PubMed]
  • Barton BE. IL-6: insights into novel biological activities. Clin Immunol Immunopathol. 1997 Oct;85(1):16–20. [PubMed]
  • Sheth R, Anderson J, Sato T, Oh B, Hempson SJ, Rollo E, Mackow ER, Shaw RD. Rotavirus stimulates IL-8 secretion from cultured epithelial cells. Virology. 1996 Jul 15;221(2):251–259. [PubMed]
  • Eckmann L, Kagnoff MF, Fierer J. Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect Immun. 1993 Nov;61(11):4569–4574. [PMC free article] [PubMed]
  • Pender SL, Tickle SP, Docherty AJ, Howie D, Wathen NC, MacDonald TT. A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol. 1997 Feb 15;158(4):1582–1590. [PubMed]
  • Meddings JB. Review article: Intestinal permeability in Crohn's disease. Aliment Pharmacol Ther. 1997 Dec;11 (Suppl 3):47–56. [PubMed]
  • Welsh FK, Farmery SM, MacLennan K, Sheridan MB, Barclay GR, Guillou PJ, Reynolds JV. Gut barrier function in malnourished patients. Gut. 1998 Mar;42(3):396–401. [PMC free article] [PubMed]
  • Fink MP. Effect of critical illness on microbial translocation and gastrointestinal mucosa permeability. Semin Respir Infect. 1994 Dec;9(4):256–260. [PubMed]
  • Lewis SA, Berg JR, Kleine TJ. Modulation of epithelial permeability by extracellular macromolecules. Physiol Rev. 1995 Jul;75(3):561–589. [PubMed]
  • Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology. 1995 May;108(5):1566–1581. [PubMed]
  • Artursson P, Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun. 1991 Mar 29;175(3):880–885. [PubMed]
  • Balda MS, Whitney JA, Flores C, González S, Cereijido M, Matter K. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol. 1996 Aug;134(4):1031–1049. [PMC free article] [PubMed]
  • Anderson JM, Van Itallie CM. Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol. 1995 Oct;269(4 Pt 1):G467–G475. [PubMed]
  • Madara JL, Parkos C, Colgan S, Nusrat A, Atisook K, Kaoutzani P. The movement of solutes and cells across tight junctions. Ann N Y Acad Sci. 1992;664:47–60. [PubMed]
  • Madara JL, Stafford J. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest. 1989 Feb;83(2):724–727. [PMC free article] [PubMed]
  • Planchon SM, Martins CA, Guerrant RL, Roche JK. Regulation of intestinal epithelial barrier function by TGF-beta 1. Evidence for its role in abrogating the effect of a T cell cytokine. J Immunol. 1994 Dec 15;153(12):5730–5739. [PubMed]
  • Matthews JB, Smith JA, Hrnjez BJ. Effects of F-actin stabilization or disassembly on epithelial Cl- secretion and Na-K-2Cl cotransport. Am J Physiol. 1997 Jan;272(1 Pt 1):C254–C262. [PubMed]
  • Zünd G, Madara JL, Dzus AL, Awtrey CS, Colgan SP. Interleukin-4 and interleukin-13 differentially regulate epithelial chloride secretion. J Biol Chem. 1996 Mar 29;271(13):7460–7464. [PubMed]
  • Hilton DJ, Zhang JG, Metcalf D, Alexander WS, Nicola NA, Willson TA. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):497–501. [PMC free article] [PubMed]
  • Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, DeWoody KL, Schaible TF, Rutgeerts PJ. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med. 1997 Oct 9;337(15):1029–1035. [PubMed]
  • Stack WA, Mann SD, Roy AJ, Heath P, Sopwith M, Freeman J, Holmes G, Long R, Forbes A, Kamm MA. Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease. Lancet. 1997 Feb 22;349(9051):521–524. [PubMed]
  • Mullin JM, Laughlin KV, Marano CW, Russo LM, Soler AP. Modulation of tumor necrosis factor-induced increase in renal (LLC-PK1) transepithelial permeability. Am J Physiol. 1992 Nov;263(5 Pt 2):F915–F924. [PubMed]
  • Mullin JM, Snock KV. Effect of tumor necrosis factor on epithelial tight junctions and transepithelial permeability. Cancer Res. 1990 Apr 1;50(7):2172–2176. [PubMed]
  • Zareie M, McKay DM, Kovarik GG, Perdue MH. Monocyte/macrophages evoke epithelial dysfunction: indirect role of tumor necrosis factor-alpha. Am J Physiol. 1998 Oct;275(4 Pt 1):C932–C939. [PubMed]
  • McKay DM, Croitoru K, Perdue MH. T cell-monocyte interactions regulate epithelial physiology in a coculture model of inflammation. Am J Physiol. 1996 Feb;270(2 Pt 1):C418–C428. [PubMed]
  • Taylor CT, Murphy A, Kelleher D, Baird AW. Changes in barrier function of a model intestinal epithelium by intraepithelial lymphocytes require new protein synthesis by epithelial cells. Gut. 1997 May;40(5):634–640. [PMC free article] [PubMed]
  • Taylor CT, Dzus AL, Colgan SP. Autocrine regulation of epithelial permeability by hypoxia: role for polarized release of tumor necrosis factor alpha. Gastroenterology. 1998 Apr;114(4):657–668. [PubMed]
  • Madsen KL, Lewis SA, Tavernini MM, Hibbard J, Fedorak RN. Interleukin 10 prevents cytokine-induced disruption of T84 monolayer barrier integrity and limits chloride secretion. Gastroenterology. 1997 Jul;113(1):151–159. [PubMed]
  • Hiribarren A, Heyman M, L'Helgouac'h A, Desjeux JF. Effect of cytokines on the epithelial function of the human colon carcinoma cell line HT29 cl 19A. Gut. 1993 May;34(5):616–620. [PMC free article] [PubMed]
  • Tsujimoto M, Yip YK, Vilcek J. Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor. J Immunol. 1986 Apr 1;136(7):2441–2444. [PubMed]
  • McKay DM, Singh PK. Superantigen activation of immune cells evokes epithelial (T84) transport and barrier abnormalities via IFN-gamma and TNF alpha: inhibition of increased permeability, but not diminished secretory responses by TGF-beta2. J Immunol. 1997 Sep 1;159(5):2382–2390. [PubMed]
  • Lu J, Philpott DJ, Saunders PR, Perdue MH, Yang PC, McKay DM. Epithelial ion transport and barrier abnormalities evoked by superantigen-activated immune cells are inhibited by interleukin-10 but not interleukin-4. J Pharmacol Exp Ther. 1998 Oct;287(1):128–136. [PubMed]
  • van Deventer SJ, Elson CO, Fedorak RN. Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group. Gastroenterology. 1997 Aug;113(2):383–389. [PubMed]
  • Ciacci C, Lind SE, Podolsky DK. Transforming growth factor beta regulation of migration in wounded rat intestinal epithelial monolayers. Gastroenterology. 1993 Jul;105(1):93–101. [PubMed]
  • Dignass AU, Podolsky DK. Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor beta. Gastroenterology. 1993 Nov;105(5):1323–1332. [PubMed]
  • Nusrat A, Parkos CA, Liang TW, Carnes DK, Madara JL. Neutrophil migration across model intestinal epithelia: monolayer disruption and subsequent events in epithelial repair. Gastroenterology. 1997 Nov;113(5):1489–1500. [PubMed]
  • McRoberts JA, Riley NE. Regulation of T84 cell monolayer permeability by insulin-like growth factors. Am J Physiol. 1992 Jan;262(1 Pt 1):C207–C213. [PubMed]
  • Uribe JM, Barrett KE. Nonmitogenic actions of growth factors: an integrated view of their role in intestinal physiology and pathophysiology. Gastroenterology. 1997 Jan;112(1):255–268. [PubMed]
  • Kaoutzani P, Colgan SP, Cepek KL, Burkard PG, Carlson S, Delp-Archer C, Brenner MB, Madara JL. Reconstitution of cultured intestinal epithelial monolayers with a mucosal-derived T lymphocyte cell line. Modulation of epithelial phenotype dependent on lymphocyte-basolateral membrane apposition. J Clin Invest. 1994 Aug;94(2):788–796. [PMC free article] [PubMed]
  • Heyman M, Darmon N, Dupont C, Dugas B, Hirribaren A, Blaton MA, Desjeux JF. Mononuclear cells from infants allergic to cow's milk secrete tumor necrosis factor alpha, altering intestinal function. Gastroenterology. 1994 Jun;106(6):1514–1523. [PubMed]
  • Rodriguez P, Heyman M, Candalh C, Blaton MA, Bouchaud C. Tumour necrosis factor-alpha induces morphological and functional alterations of intestinal HT29 cl.19A cell monolayers. Cytokine. 1995 Jul;7(5):441–448. [PubMed]
  • Alican I, Kubes P. A critical role for nitric oxide in intestinal barrier function and dysfunction. Am J Physiol. 1996 Feb;270(2 Pt 1):G225–G237. [PubMed]
  • Gaginella TS, Kachur JF, Tamai H, Keshavarzian A. Reactive oxygen and nitrogen metabolites as mediators of secretory diarrhea. Gastroenterology. 1995 Dec;109(6):2019–2028. [PubMed]
  • Eckmann L, Stenson WF, Savidge TC, Lowe DC, Barrett KE, Fierer J, Smith JR, Kagnoff MF. Role of intestinal epithelial cells in the host secretory response to infection by invasive bacteria. Bacterial entry induces epithelial prostaglandin h synthase-2 expression and prostaglandin E2 and F2alpha production. J Clin Invest. 1997 Jul 15;100(2):296–309. [PMC free article] [PubMed]
  • Kernéis S, Bogdanova A, Kraehenbuhl JP, Pringault E. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science. 1997 Aug 15;277(5328):949–952. [PubMed]
  • Neutra MR, Frey A, Kraehenbuhl JP. Epithelial M cells: gateways for mucosal infection and immunization. Cell. 1996 Aug 9;86(3):345–348. [PubMed]
  • Savidge TC, Smith MW, James PS, Aldred P. Salmonella-induced M-cell formation in germ-free mouse Peyer's patch tissue. Am J Pathol. 1991 Jul;139(1):177–184. [PMC free article] [PubMed]
  • Borghesi C, Regoli M, Bertelli E, Nicoletti C. Modifications of the follicle-associated epithelium by short-term exposure to a non-intestinal bacterium. J Pathol. 1996 Nov;180(3):326–332. [PubMed]
  • Galán JE, Bliska JB. Cross-talk between bacterial pathogens and their host cells. Annu Rev Cell Dev Biol. 1996;12:221–255. [PubMed]
  • Hershberg RM, Framson PE, Cho DH, Lee LY, Kovats S, Beitz J, Blum JS, Nepom GT. Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing. J Clin Invest. 1997 Jul 1;100(1):204–215. [PMC free article] [PubMed]
  • Mayer L, So LP, Yio XY, Small G. Antigen trafficking in the intestine. Ann N Y Acad Sci. 1996 Feb 13;778:28–35. [PubMed]
  • Neumann B, Luz A, Pfeffer K, Holzmann B. Defective Peyer's patch organogenesis in mice lacking the 55-kD receptor for tumor necrosis factor. J Exp Med. 1996 Jul 1;184(1):259–264. [PMC free article] [PubMed]
  • Mayrhofer G. Peyer's patch organogenesis--cytokines rule, OK? Gut. 1997 Nov;41(5):707–709. [PMC free article] [PubMed]
  • Pasparakis M, Alexopoulou L, Grell M, Pfizenmaier K, Bluethmann H, Kollias G. Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor. Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6319–6323. [PMC free article] [PubMed]
  • Orchard T, Jewell DP. Review article: Pathophysiology of the intestinal mucosa in inflammatory bowel disease and arthritis: similarities and dissimilarities in clinical findings. Aliment Pharmacol Ther. 1997 Dec;11 (Suppl 3):10–16. [PubMed]
  • Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, Berelowitz M, Dhillon AP, Thomson MA, Harvey P, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998 Feb 28;351(9103):637–641. [PubMed]
  • Holmgren J, Fryklund J, Larsson H. Gamma-interferon-mediated down-regulation of electrolyte secretion by intestinal epithelial cells: a local immune mechanism? Scand J Immunol. 1989 Oct;30(4):499–503. [PubMed]
  • Chiossone DC, Simon PL, Smith PL. Interleukin-1: effects on rabbit ileal mucosal ion transport in vitro. Eur J Pharmacol. 1990 May 16;180(2-3):217–228. [PubMed]
  • Kandil HM, Berschneider HM, Argenzio RA. Tumour necrosis factor alpha changes porcine intestinal ion transport through a paracrine mechanism involving prostaglandins. Gut. 1994 Jul;35(7):934–940. [PMC free article] [PubMed]
  • Berschneider HM, Powell DW. Fibroblasts modulate intestinal secretory responses to inflammatory mediators. J Clin Invest. 1992 Feb;89(2):484–489. [PMC free article] [PubMed]
  • Compeau CG, Rotstein OD, Tohda H, Marunaka Y, Rafii B, Slutsky AS, O'Brodovich H. Endotoxin-stimulated alveolar macrophages impair lung epithelial Na+ transport by an L-Arg-dependent mechanism. Am J Physiol. 1994 May;266(5 Pt 1):C1330–C1341. [PubMed]
  • Ciacci C, Mahida YR, Dignass A, Koizumi M, Podolsky DK. Functional interleukin-2 receptors on intestinal epithelial cells. J Clin Invest. 1993 Jul;92(1):527–532. [PMC free article] [PubMed]
  • Madsen KL, Tavernini MM, Mosmann TR, Fedorak RN. Interleukin 10 modulates ion transport in rat small intestine. Gastroenterology. 1996 Oct;111(4):936–944. [PubMed]
  • Shapiro M, Matthews J, Hecht G, Delp C, Madara JL. Stabilization of F-actin prevents cAMP-elicited Cl- secretion in T84 cells. J Clin Invest. 1991 Jun;87(6):1903–1909. [PMC free article] [PubMed]
  • Matthews JB, Awtrey CS, Madara JL. Microfilament-dependent activation of Na+/K+/2Cl- cotransport by cAMP in intestinal epithelial monolayers. J Clin Invest. 1992 Oct;90(4):1608–1613. [PMC free article] [PubMed]
  • Opleta-Madsen K, Hardin J, Gall DG. Epidermal growth factor upregulates intestinal electrolyte and nutrient transport. Am J Physiol. 1991 Jun;260(6 Pt 1):G807–G814. [PubMed]
  • Uribe JM, Gelbmann CM, Traynor-Kaplan AE, Barrett KE. Epidermal growth factor inhibits Ca(2+)-dependent Cl- transport in T84 human colonic epithelial cells. Am J Physiol. 1996 Sep;271(3 Pt 1):C914–C922. [PubMed]
  • Uribe JM, Keely SJ, Traynor-Kaplan AE, Barrett KE. Phosphatidylinositol 3-kinase mediates the inhibitory effect of epidermal growth factor on calcium-dependent chloride secretion. J Biol Chem. 1996 Oct 25;271(43):26588–26595. [PubMed]
  • Borok Z, Hami A, Danto SI, Lubman RL, Kim KJ, Crandall ED. Effects of EGF on alveolar epithelial junctional permeability and active sodium transport. Am J Physiol. 1996 Apr;270(4 Pt 1):L559–L565. [PubMed]
  • Hecht G, Pestic L, Nikcevic G, Koutsouris A, Tripuraneni J, Lorimer DD, Nowak G, Guerriero V, Jr, Elson EL, Lanerolle PD. Expression of the catalytic domain of myosin light chain kinase increases paracellular permeability. Am J Physiol. 1996 Nov;271(5 Pt 1):C1678–C1684. [PubMed]
  • Shanahan F. Designer drugs for inflammatory bowel disease. Gastroenterology. 1997 Jun;112(6):2153–2154. [PubMed]
  • Neurath MF, Pettersson S, Meyer zum Büschenfelde KH, Strober W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med. 1996 Sep;2(9):998–1004. [PubMed]
  • Keates S, Hitti YS, Upton M, Kelly CP. Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells. Gastroenterology. 1997 Oct;113(4):1099–1109. [PubMed]
  • Jobin C, Haskill S, Mayer L, Panja A, Sartor RB. Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells. J Immunol. 1997 Jan 1;158(1):226–234. [PubMed]
  • Ihle JN. STATs: signal transducers and activators of transcription. Cell. 1996 Feb 9;84(3):331–334. [PubMed]
  • Reinecker HC, MacDermott RP, Mirau S, Dignass A, Podolsky DK. Intestinal epithelial cells both express and respond to interleukin 15. Gastroenterology. 1996 Dec;111(6):1706–1713. [PubMed]
  • Warhurst AC, Hopkins SJ, Warhurst G. Interferon gamma induces differential upregulation of alpha and beta chemokine secretion in colonic epithelial cell lines. Gut. 1998 Feb;42(2):208–213. [PMC free article] [PubMed]
  • Grimm MC, Elsbury SK, Pavli P, Doe WF. Interleukin 8: cells of origin in inflammatory bowel disease. Gut. 1996 Jan;38(1):90–98. [PMC free article] [PubMed]
  • Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993 Oct 22;75(2):263–274. [PubMed]
  • Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 1993 Oct 22;75(2):253–261. [PubMed]
  • Sartor RB. Review article: Role of the enteric microflora in the pathogenesis of intestinal inflammation and arthritis. Aliment Pharmacol Ther. 1997 Dec;11 (Suppl 3):17–23. [PubMed]
  • Sears CL, Kaper JB. Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microbiol Rev. 1996 Mar;60(1):167–215. [PMC free article] [PubMed]
  • Yamada T, Sartor RB, Marshall S, Specian RD, Grisham MB. Mucosal injury and inflammation in a model of chronic granulomatous colitis in rats. Gastroenterology. 1993 Mar;104(3):759–771. [PubMed]
  • Rook GA, Stanford JL. Give us this day our daily germs. Immunol Today. 1998 Mar;19(3):113–116. [PubMed]
  • Strober W, Kelsall B. To be responsive or not to be responsive, that is the mucosal question. Gastroenterology. 1998 Jan;114(1):214–217. [PubMed]
  • Eldridge JH, Staas JK, Chen D, Marx PA, Tice TR, Gilley RM. New advances in vaccine delivery systems. Semin Hematol. 1993 Oct;30(4 Suppl 4):16–25. [PubMed]
  • Powell MF. Drug delivery issues in vaccine development. Pharm Res. 1996 Dec;13(12):1777–1785. [PubMed]
  • Marinaro M, Boyaka PN, Finkelman FD, Kiyono H, Jackson RJ, Jirillo E, McGhee JR. Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses. J Exp Med. 1997 Feb 3;185(3):415–427. [PMC free article] [PubMed]
  • Monteleone G, Biancone L, Marasco R, Morrone G, Marasco O, Luzza F, Pallone F. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology. 1997 Apr;112(4):1169–1178. [PubMed]
  • Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Büschenfelde KH. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) Clin Exp Immunol. 1995 Dec;102(3):448–455. [PMC free article] [PubMed]
  • Bramson JL, Graham FL, Gauldie J. The use of adenoviral vectors for gene therapy and gene transfer in vivo. Curr Opin Biotechnol. 1995 Oct;6(5):590–595. [PubMed]
  • Jobin C, Panja A, Hellerbrand C, Iimuro Y, Didonato J, Brenner DA, Sartor RB. Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor kappaB super-repressor in human intestinal epithelial cells. J Immunol. 1998 Jan 1;160(1):410–418. [PubMed]
  • Hyde SC, Gill DR, Higgins CF, Trezise AE, MacVinish LJ, Cuthbert AW, Ratcliff R, Evans MJ, Colledge WH. Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature. 1993 Mar 18;362(6417):250–255. [PubMed]
  • Brown GR, Thiele DL, Silva M, Beutler B. Adenoviral vectors given intravenously to immunocompromised mice yield stable transduction of the colonic epithelium. Gastroenterology. 1997 May;112(5):1586–1594. [PubMed]
  • Croyle MA, Walter E, Janich S, Roessler BJ, Amidon GL. Role of integrin expression in adenovirus-mediated gene delivery to the intestinal epithelium. Hum Gene Ther. 1998 Mar 1;9(4):561–573. [PubMed]

Figures and Tables

Figure 1
Intestinal epithelial cells express various cytokines either constitutively or in response to stimuli including other cytokines or microorganisms. Epithelial cells also express receptors for a number of different cytokines. Thus cytokines (and other ...
Figure 2
Impaired epithelial permeability, whether in response to cytokines or other stimuli, reduces barrier function. Increased exposure to luminal contents will activate lamina propria cells with consequent generation of pro-inflammatory cytokines. These may exacerbate ...
Figure 3
Cytokines and mucosal protection. The epithelium is involved in deployment of a number of effector mechanisms of innate and adaptive immunity. In terms of sensory function, antigen delivery requires trafficking (and perhaps processing) of antigens across ...

Articles from Gut are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...